A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
PHASE2CompletedINTERVENTIONAL
Enrollment
102
Participants
Timeline
Start Date
July 31, 1988
Study Completion Date
April 30, 1990
Conditions
Acquired Immunodeficiency SyndromeAnemia
Interventions
DRUG
epoetin alfa
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00270283 - A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy | Biotech Hunter | Biotech Hunter